ALEXIS FOUNTAIN: Open Payments
NPI 1821724386 · VIDALIA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 37 payments from 13 companies in 2025. Trend: 2023 $219 · 2024 $321 · 2025 $690
Food & beverage: $690
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $180 |
| Lilly USA, LLC | 4 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $71 |
| Inspire Medical Systems, Inc. | 3 | $67 |
| Corcept Therapeutics | 2 | $41 |
| Esperion Therapeutics, Inc. | 2 | $40 |
| Amgen Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Novo Nordisk Inc | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $35 |
Products named: VRAYLAR, MOUNJARO, INSPIRE, Korlym, AIRSUPRA, NEXLETOL, OTEZLA, CAPLYTA.
Industry payments across GA — which companies pay providers there.
